Application
CSAG2 Antibody (N-term) western blot analysis in ZR-75-1 cell line lysates (35ug/lane).This demonstrates the CSAG2 antibody detected the CSAG2 protein (arrow).Application
CSAG2 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human lung carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the CSAG2 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | CSAG2 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CSAG2; TRAG3; Chondrosarcoma-associated gene 2/3 protein; Cancer/testis antigen 24.2; Taxol-resistant-associated gene 3 protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | TRAG3 |
|---|---|
| Alternative Names | CSAG2 TRAG3 Chondrosarcoma-associated gene 2/3 protein Cancer/testis antigen 24.2 Taxol-resistant-associated gene 3 protein |
| Molecular Weight(MW) | 14430 Da |
| Function | Drug-resistance related protein, its expression is associated with the chemotherapy resistant and neoplastic phenotype. May also be linked to the malignant phenotype |
| Tissue Specificity | Weakly expressed in kidney. Expressed in various tumor cell lines including carcinomas, myeloid and lymphoid malignancies, melanomas and prostate cancer Overexpressed in taxol-resistant breast cancer line MDA 435TR and the doxorubicin-resistant multiple myelanoma lines RPMI-8226/Dox40 and RPMI-8226/MDR10V |
| Entrez Gene | 728461 |
|---|---|
| Nucleotide Accession | NP_001074317.2 NP_001123300.1 NP_001123298.1 NP_004900.2 |
Application
CSAG2 Antibody (N-term) western blot analysis in ZR-75-1 cell line lysates (35ug/lane).This demonstrates the CSAG2 antibody detected the CSAG2 protein (arrow).
Application
CSAG2 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human lung carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the CSAG2 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
